Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawei Ma

Showing results (191-200 of 197) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 197 results.
Journal of Medicinal Chemistry|March 19, 2026
Structure-Based Design of Potent and Highly Selective NUAK1 Inhibitors by Exploiting a Unique Glutamate Switch for the Prevention of Tumor Growth, Migration, and InvasionShan Li, Yingao Wang, Xuechen Liu, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2010
Studies on the structure-activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 1: Tuning the N-substituentsLi Ben, Eric Dale Jones, Enkun Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Studies on the structure-activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 2: Discovery of highly potent anti-HIV agentsBen Li, Eric Dale Jones, Enkun Zhou, et al.
Journal of Medicinal Chemistry|May 3, 2013
Pyridinylquinazolines selectively inhibit human methionine aminopeptidase-1 in cellsFeiran Zhang, Shridhar Bhat, Sandra B Gabelli, et al.
Plos Biology|September 1, 2005
Design of wide-spectrum inhibitors targeting coronavirus main proteasesHaitao Yang, Weiqing Xie, Xiaoyu Xue, et al.
Cell|October 4, 2011
Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13Junli Liu, Hongguang Xia, Minsu Kim, et al.
Journal of Medicinal Chemistry|November 23, 2011
Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptorQing Liu, Na Li, Yunyun Yuan, et al.
Pageof 20

Showing results (191-200 of 197) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 197 results.
Journal of Medicinal Chemistry|March 19, 2026
Structure-Based Design of Potent and Highly Selective NUAK1 Inhibitors by Exploiting a Unique Glutamate Switch for the Prevention of Tumor Growth, Migration, and InvasionShan Li, Yingao Wang, Xuechen Liu, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2010
Studies on the structure-activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 1: Tuning the N-substituentsLi Ben, Eric Dale Jones, Enkun Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Studies on the structure-activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 2: Discovery of highly potent anti-HIV agentsBen Li, Eric Dale Jones, Enkun Zhou, et al.
Journal of Medicinal Chemistry|May 3, 2013
Pyridinylquinazolines selectively inhibit human methionine aminopeptidase-1 in cellsFeiran Zhang, Shridhar Bhat, Sandra B Gabelli, et al.
Plos Biology|September 1, 2005
Design of wide-spectrum inhibitors targeting coronavirus main proteasesHaitao Yang, Weiqing Xie, Xiaoyu Xue, et al.
Cell|October 4, 2011
Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13Junli Liu, Hongguang Xia, Minsu Kim, et al.
Journal of Medicinal Chemistry|November 23, 2011
Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptorQing Liu, Na Li, Yunyun Yuan, et al.
Pageof 20